Happy Biofarma GAAP每股收益为-0.09美元

2025-10-30 05:49

Helix Biopharma press release (OTCPK:HBPCF): FY GAAP EPS of -$0.09.
As at July 31, 2025, the Company’s cash reserves of $65,000 are insufficient to meet anticipated cash needs for working capital and capital expenditures through the next twelve months, nor are they sufficient to see the current research and development initiates through to completion. To theextent that the Company does not believe it has sufficient liquidity to meet its current obligations, management considers securing additional funds primarily through equity arrangements to be of utmost importance.

More on Helix BioPharma Corp.